Show simple item record

dc.contributor.authorRaynsford, Justine*
dc.contributor.authorDada, C.*
dc.contributor.authorStansfield, D.*
dc.contributor.authorCullen, T.*
dc.date.accessioned2018-07-30T12:18:32Z
dc.date.available2018-07-30T12:18:32Z
dc.date.issued2020
dc.identifier.citationRaynsford J, Dada C, Stansfield D and Cullen T (2020) Impact of a specialist mental health pharmacy team on medicines optimisation in primary care for patients on a severe mental illness register: a pilot study. European Journal of Hospital Pharmacy. 27(1): 31-35.en_US
dc.identifier.urihttp://hdl.handle.net/10454/16516
dc.descriptionyesen_US
dc.description.abstractObjective Medication arrangements for patients with severe mental illness (SMI), including schizophrenia and bipolar disorder, can be complex. Some have shared care between primary and secondary services while others have little specialist input. This study investigated the contribution a specialist mental health clinical pharmacy team could make to medicines optimisation for patients on the SMI register in primary care. Research shows that specialist mental health pharmacists improve care in inpatient settings. However, little is known about their potential impact in primary care. Method Five general practice surgeries were allocated half a day per week of a specialist pharmacist and technician for 12 months. The technician reviewed primary and secondary care records for discrepancies. Records were audited for high-dose or multiple antipsychotics, physical health monitoring and adherence. Issues were referred to the pharmacist for review. Surgery staff were encouraged to refer psychotropic medication queries to the team. Interventions were recorded and graded. Results 316/472 patients on the SMI register were prescribed antipsychotics or mood stabilisers. 23 (7%) records were updated with missing clozapine and depot information. Interventions by the pharmacist included clarifying discharge information (12/104), reviewing high-dose and multiple antipsychotic prescribing (18/104), correcting errors (10/104), investigating adherence issues (16/104), following up missing health checks (22/104) and answering queries from surgery staff (23/104). Five out of six interventions possibly preventing hospital admission were for referral of non-adherent patients. Conclusion The pharmacy team found a variety of issues including incomplete medicines reconciliation, adherence issues, poor communication, drug errors and the need for specialist advice. The expertise of the team enabled timely resolution of issues and bridges were built between primary and secondary care.en_US
dc.language.isoenen_US
dc.relation.isreferencedbyhttp://dx.doi.org/10.1136/ejhpharm-2018-001514en_US
dc.rights© 2020 The Authors. Published by BMJ Publishing Group and reproduced in accordance with the publisher's self-archiving policy.
dc.subjectSpecialist mental health pharmacyen_US
dc.subjectSevere mental illness (SMI)en_US
dc.subjectSevere mental illness registeren_US
dc.subjectPharmacistsen_US
dc.subjectPrimary careen_US
dc.subjectMedicines optimisationen_US
dc.titleImpact of a specialist mental health pharmacy team on medicines optimisation in primary care for patients on a severe mental illness register: a pilot studyen_US
dc.status.refereedYesen_US
dc.date.Accepted2018-06-14
dc.date.application2018-07-02
dc.typeArticleen_US
dc.type.versionAccepted manuscripten_US
refterms.dateFOA2018-07-30T12:18:36Z


Item file(s)

Thumbnail
Name:
ejhpharm-2018-001514.pdf
Size:
197.9Kb
Format:
PDF
Description:
Keep suppressed - published ...
Thumbnail
Name:
Impact of a specialist MH pharmacy ...
Size:
333.1Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record